These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34057612)

  • 1. A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease.
    Veeraphan P; Chavasiri W; Muanprasat C; Chatsudthipong V; Yuajit C
    Clin Exp Nephrol; 2021 Sep; 25(9):944-952. PubMed ID: 34057612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease.
    Yuajit C; Muanprasat C; Gallagher AR; Fedeles SV; Kittayaruksakul S; Homvisasevongsa S; Somlo S; Chatsudthipong V
    Biochem Pharmacol; 2014 Apr; 88(3):412-21. PubMed ID: 24518257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steviol reduces MDCK Cyst formation and growth by inhibiting CFTR channel activity and promoting proteasome-mediated CFTR degradation.
    Yuajit C; Homvisasevongsa S; Chatsudthipong L; Soodvilai S; Muanprasat C; Chatsudthipong V
    PLoS One; 2013; 8(3):e58871. PubMed ID: 23536832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pranlukast inhibits renal epithelial cyst progression via activation of AMP-activated protein kinase.
    Pathomthongtaweechai N; Soodvilai S; Chatsudthipong V; Muanprasat C
    Eur J Pharmacol; 2014 Feb; 724():67-76. PubMed ID: 24360935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion.
    Nantavishit J; Chatsudthipong V; Soodvilai S
    Biochem Pharmacol; 2018 Aug; 154():175-182. PubMed ID: 29746821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel action of the chalcone isoliquiritigenin as a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor: potential therapy for cholera and polycystic kidney disease.
    Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
    J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 22186622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel chalcone derivative inhibiting CFTR chloride channel via AMPK activation and its anti-diarrheal application.
    Yibcharoenporn C; Chusuth P; Jakakul C; Rungrotmongkol T; Chavasiri W; Muanprasat C
    J Pharmacol Sci; 2019 Jul; 140(3):273-283. PubMed ID: 31444000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Effects of Panduratin A on Renal Cyst Development in In Vitro and In Vivo Models of Polycystic Kidney Disease.
    Tonum K; Srimai N; Chabang N; Fongsupa S; Tuchinda P; Torres JA; Weimbs T; Soodvilai S
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of farnesoid X receptor retards expansion of renal collecting duct cell-derived cysts via inhibition of CFTR-mediated Cl
    Srimai N; Tonum K; Soodvilai S
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F600-F610. PubMed ID: 38299213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Application of Gambogic Acid for Retarding Renal Cyst Progression in Polycystic Kidney Disease.
    Khunpatee N; Bhukhai K; Chatsudthipong V; Yuajit C
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Action of the Chalcone Isoliquiritigenin as a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor: Potential Therapy for Cholera and Polycystic Kidney Disease.
    Muanprasat C; Sirianant L; Soodvilai S; Chokchaisiri R; Suksamrarn A; Chatsudthipong V
    J Pharmacol Sci; 2012; 118(1):82-91. PubMed ID: 32092841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinostrobin inhibits renal CFTR-mediated Cl
    Tonum K; Chabang N; Fongsupa S; Chantawarin S; Jiarpinitnun C; Tuchinda P; Soodvilai S
    J Pharmacol Sci; 2022 Apr; 148(4):369-376. PubMed ID: 35300812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models.
    Zhou H; Gao J; Zhou L; Li X; Li W; Li X; Xia Y; Yang B
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1234-42. PubMed ID: 22338085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin inhibits renal cyst formation and enlargement in vitro by regulating intracellular signaling pathways.
    Gao J; Zhou H; Lei T; Zhou L; Li W; Li X; Yang B
    Eur J Pharmacol; 2011 Mar; 654(1):92-9. PubMed ID: 21187084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steviol stabilizes polycystin 1 expression and promotes lysosomal degradation of CFTR and β-catenin proteins in renal epithelial cells.
    Yuajit C; Muanprasat C; Homvisasevongsa S; Chatsudthipong V
    Biomed Pharmacother; 2017 Oct; 94():820-826. PubMed ID: 28802235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
    Li H; Findlay IA; Sheppard DN
    Kidney Int; 2004 Nov; 66(5):1926-38. PubMed ID: 15496164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV; Zhou JX; Magenheimer BS; Reif GA; Wallace DP; Georg GI; Jakkaraj SR; Tash JS; Yu ASL; Li X; Calvet JP
    Am J Physiol Renal Physiol; 2022 Oct; 323(4):F492-F506. PubMed ID: 35979967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease.
    Wang W; Geng X; Lei L; Jia Y; Li Y; Zhou H; Verkman AS; Yang B
    FASEB J; 2019 May; 33(5):6185-6196. PubMed ID: 30768374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.